ELISA genotyping of hepatitis B virus in China with antibodies specific for genotypes B and C.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
12 Oct 2024
Historique:
received: 13 05 2024
accepted: 09 10 2024
medline: 13 10 2024
pubmed: 13 10 2024
entrez: 12 10 2024
Statut: epublish

Résumé

Hepatitis B virus (HBV) causes hepatitis B (HB) and distinct HBV genotypes can lead to different prognoses. However, HBV genotyping is rarely done in clinics, because the traditional method by PCR-based DNA sequencing is impractical for clinical diagnosis with tedious process and low success rate. Herein, we have established an ELISA-based genotyping method to quickly determine the HBV genotypes of HB patients in China. First, two commercial antibodies, 16D12 and 6H3 specific for HBV genotypes B and C respectively, are chosen as capture antibodies, since these two genotypes dominate in China. Then two home-made genotype-specific antibodies, B19 and C04, are used as the detection antibodies for genotypes B and C in sandwiched ELISA. The ELISA kit shows high sensitivity (> 95%) and specificity (> 95%) in detecting genotypes B and C of Chinese HB patients. Moreover, the ELISA kit has demonstrated higher success rate (98.7%) than PCR-based DNA sequencing (93.5%) and a commercial PCR-based genotyping kit (92.2%) for sera with HBV DNA ≥ 1000 IU/mL and HBsAg ≥ 250 IU/mL. Such an advantage is more obvious for the sera with HBV DNA < 1000 IU/mL. The kappa analysis between the ELISA and PCR-based DNA sequencing results exhibits a kappa of 0.836, indicating a good correlation.

Identifiants

pubmed: 39396069
doi: 10.1038/s41598-024-76023-7
pii: 10.1038/s41598-024-76023-7
doi:

Substances chimiques

DNA, Viral 0
Hepatitis B Antibodies 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

23884

Subventions

Organisme : National Key Research and Development Program of China
ID : 2017ZX106080
Organisme : National Key Research and Development Program of China
ID : 2022YFE0138500
Organisme : National Key Research and Development Program of China
ID : 2017ZX106080
Organisme : National Key Research and Development Program of China
ID : 2017ZX106080
Organisme : National Key Research and Development Program of China
ID : 2017ZX106080
Organisme : National Key Research and Development Program of China
ID : 2017ZX106080

Informations de copyright

© 2024. The Author(s).

Références

Zheng, Q. et al. Single-cell landscape identifies the immunophenotypes and microenvironments of HBV-positive and HBV-negative liver cancer. Hepatol.Commun. 8, e0364. https://doi.org/10.1097/hc9.0000000000000364 (2024).
doi: 10.1097/hc9.0000000000000364 pubmed: 38251896 pmcid: 10805423
Kumar, M. et al. Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy. Hepatol. Int. 16, 211–253 (2022).
doi: 10.1007/s12072-021-10285-5 pubmed: 35113359
Chen, L. et al. HBV core promoter mutations and AKT upregulate S-phase kinase-associated protein 2 to promote postoperative hepatocellular carcinoma progression. Sci. Rep. 6, 35917. https://doi.org/10.1038/srep35917 (2016).
doi: 10.1038/srep35917 pubmed: 27779207 pmcid: 5078796
Congly, S. E. et al. Characterization of hepatitis B virus genotypes and quantitative hepatitis B surface antigen titres in north American tertiary referral liver centres. Liver Int. 33, 1363–1369 (2013).
doi: 10.1111/liv.12222 pubmed: 23763288
Tong, S. & Revill, P. Overview of hepatitis B viral replication and genetic variability. J. Hepatol. 64, 4–16 (2016).
doi: 10.1016/j.jhep.2016.01.027 pubmed: 27084035 pmcid: 4834849
Kramvis, A. Genotypes and genetic variability of Hepatitis B Virus. Intervirology. 57, 141–150 (2014).
doi: 10.1159/000360947 pubmed: 25034481
Sun, B. et al. Origin and dispersal history of Hepatitis B virus in Eastern Eurasia. Nat. Commun. 15, 2951. https://doi.org/10.1038/s41467-024-47358-6 (2024).
doi: 10.1038/s41467-024-47358-6 pubmed: 38580660 pmcid: 10997587
Velkov, S., Ott, J. J., Protzer, U. & Michler, T. The Global Hepatitis B Virus Genotype Distribution Approximated from Available Genotyping Data. Genes. 9, 495. https://doi.org/10.3390/genes9100495 (2018).
Li, J. S. et al. Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: possible contribution of a single nucleotide in the precore region. J. Virol. 67, 5402–5410 (1993).
doi: 10.1128/jvi.67.9.5402-5410.1993 pubmed: 8350403 pmcid: 237941
Inoue, J. et al. Comparison of hepatitis B virus genotypes B and C among chronically hepatitis B virus-infected patients who received nucleos(t)ide analogs: a multicenter retrospective study. Hepatol. Res. 49, 1263–1274 (2019).
doi: 10.1111/hepr.13398 pubmed: 31254482
Bowden, D. S. & Thompson, A. J. New developments in HBV molecular diagnostics and quantitative serology. Hepatol. Int. 2, 3–11 (2008).
doi: 10.1007/s12072-008-9051-8 pubmed: 19669293 pmcid: 2716842
Sugauchi, F. et al. Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C. Gastroenterology. 124, 925–932 (2003).
doi: 10.1053/gast.2003.50140 pubmed: 12671889
Locarnini, S., Littlejohn, M., Aziz, M. N. & Yuen, L. Possible origins and evolution of the hepatitis B virus (HBV). Semin Cancer Biol. 23, 561–575 (2013).
doi: 10.1016/j.semcancer.2013.08.006 pubmed: 24013024
Huy, T. T. T. et al. Characteristics of hepatitis B virus in Ghana: full length genome sequences indicate the endemicity of genotype E in West Africa. J. Med. Virol. 78, 178–184 (2006).
doi: 10.1002/jmv.20525 pubmed: 16372296
Arauz-Ruiz, P., Norder, H., Robertson, B. H. & Magnius, L. O.  Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J. Gen. Virol. 83, 2059–2073 (2002).
doi: 10.1099/0022-1317-83-8-2059 pubmed: 12124470
Ghany, M. G. et al. Characteristics of adults in the Hepatitis B Research Network in North America reflect their country of Origin and Hepatitis B Virus genotype. Clin. Gastroenterol. Hepatol. 13, 183–192 (2015).
doi: 10.1016/j.cgh.2014.06.028 pubmed: 25010003
Wang, Z. et al. A new intertype recombinant between genotypes C and D of hepatitis B virus identified in China. J. Gen. Virol. 86, 985–990 (2005).
doi: 10.1099/vir.0.80771-0 pubmed: 15784891
Tang, L. S. Y., Covert, E., Wilson, E. & Kottilil, S. Chronic Hepatitis B Infection: A Review. JAMA 319, 1802–1813 (2018).
doi: 10.1001/jama.2018.3795 pubmed: 29715359
Ito, K., Yoneda, M., Sakamoto, K. & Mizokami, M. Virological and clinical characteristics of Hepatitis B Virus genotype A. J. Gastroenterol. 53, 18–26 (2018).
doi: 10.1007/s00535-017-1367-5 pubmed: 28687901
Erhardt, A. et al. Response to interferon alfa is hepatitis B virus genotype dependent: genotype A is more sensitive to interferon than genotype D. Gut. 54, 1009–1013 (2005).
doi: 10.1136/gut.2004.060327 pubmed: 15951551 pmcid: 1774609
Shen, F. et al. Hepatitis B virus sensitivity to interferon-alpha in hepatocytes is more associated with cellular interferon response than with viral genotype. Hepatology. 67, 1237–1252 (2018).
doi: 10.1002/hep.29609 pubmed: 29059468
Deng, M., Tong, M., Fu, F. & Wei, D. Comparative untargeted metabolomics analysis of serum metabolic alterations in patients infected with hepatitis B virus genotypes B and C. Arab. J. Chem. 16, 105155. https://doi.org/10.1016/j.arabjc.2023.105155 (2023).
Chu, Y. J. et al. HBV genotype-dependent association of HLA variants with the serodecline of HBsAg in chronic hepatitis B patients. Sci. Rep. 13, 359. https://doi.org/10.1038/s41598-023-27570-y (2023).
doi: 10.1038/s41598-023-27570-y pubmed: 36611047 pmcid: 9825396
Li, J. et al. Clinical isolates of hepatitis B virus genotype C have higher in vitro transmission efficiency than genotype B isolates. J. Med. Virol. 95, e28879. https://doi.org/10.1002/jmv.28879 (2023).
doi: 10.1002/jmv.28879 pubmed: 37314050 pmcid: 10404337
Lin, C. L. & Kao, J. H. Hepatitis B virus genotypes and variants. Cold Spring Harb Perspect. Med.  5, a021436. https://doi.org/10.1101/cshperspect.a021436 (2015).
doi: 10.1101/cshperspect.a021436
Chan, H. L. Y. et al. Hepatitis B Virus genotype C is Associated with more severe liver fibrosis than Genotype B. Clin. Gastroenterol. Hepatol. 7, 1361–1366 (2009).
doi: 10.1016/j.cgh.2009.08.004 pubmed: 19683072
Ni, Y. H. et al. Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma. Gastroenterology. 127, 1733–1738 (2004).
doi: 10.1053/j.gastro.2004.09.048 pubmed: 15578511
Watanabe, K. et al. Comparative study of genotype B and C hepatitis B virus-induced chronic hepatitis in relation to the basic core promoter and precore mutations. J. Gastroenterol. Hepatol. 20, 441–449 (2005).
doi: 10.1111/j.1440-1746.2004.03572.x pubmed: 15740490
Revill, P. A. et al. The evolution and clinical impact of hepatitis B virus genome diversity. Nat. Rev. Gastroenterol. Hepatol. 17, 618–634 (2020).
doi: 10.1038/s41575-020-0296-6 pubmed: 32467580
Sukowati, C. H. C., Jayanti, S., Turyadi, T., Muljono, D. H. & Tiribelli, C. Hepatitis B virus genotypes in precision medicine of hepatitis B-related hepatocellular carcinoma: where we are now. World J. Gastrointest. Oncol. 16, 1097–1103 (2024).
doi: 10.4251/wjgo.v16.i4.1097 pubmed: 38660644 pmcid: 11037070
Lau, K. C., Osiowy, C. & Coffin, C. S. Hepatitis B virus (HBV) genome detection and genotyping in virally suppressed patients using nested polymerase chain reaction-based Sanger sequencing. Diagn. Microbiol. Infect. Dis. 93, 318–324 (2019).
doi: 10.1016/j.diagmicrobio.2018.10.015 pubmed: 30471842
Irshad, M., Gupta, P., Mankotia, D. S. & Ansari, M. A. Multiplex qPCR for serodetection and serotyping of hepatitis viruses: a brief review. World J. Gastroenterol. 20, 4824-4834 (2016).
Wang, W. et al. Establishment of a novel two-probe real-time PCR for simultaneously quantification of hepatitis B virus DNA and distinguishing genotype B from non-B genotypes. Clin. Chim. Acta. 437, 168–174 (2014).
doi: 10.1016/j.cca.2014.07.021 pubmed: 25066032
Chen, J. et al. Improved multiplex-PCR to identify hepatitis B virus genotypes A–F and subgenotypes B1, B2, C1 and C2. J. Clin. Virol. 38, 238–243 (2007).
doi: 10.1016/j.jcv.2006.12.007 pubmed: 17224304
Welzel, T. M. et al. Real-time PCR assay for detection and quantification of Hepatitis B virus genotypes a to G. J. Clin. Microbiol. 44, 3325–3333 (2006).
doi: 10.1128/jcm.00024-06 pubmed: 16954268 pmcid: 1594718
Liu, K. et al. Identifying the genotypes of Hepatitis B Virus (HBV) with DNA origami label. Small. 14, 1701718. https://doi.org/10.1002/smll.201701718 (2018).
Usuda, S. et al. Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product. J. Virol. Methods. 80, 97–112 (1999).
doi: 10.1016/S0166-0934(99)00039-7 pubmed: 10403681
Bezuglova, L. V. et al. Trial results for ELISA test kits for HBsAg Subtype and Hepatitis B Virus genotype identification in human blood plasma. Mol. Genet. Microbiol.Virol. 35, 229–236 (2020).
doi: 10.3103/S0891416820040047
Zhang, R. et al. Determination of hepatitis B virus genotype by flow-through reverse dot blot. J. Clin. Virol. 39, 94–100 (2007).
doi: 10.1016/j.jcv.2007.01.014 pubmed: 17466578
Song, L. W. et al. Rapid fluorescent lateral-flow immunoassay for hepatitis B virus genotyping. Anal. Chem. 87, 5173–5180 (2015).
doi: 10.1021/ac504832c pubmed: 25892477
Qiu, X. et al. A fast and low-cost genotyping method for hepatitis B virus based on pattern recognition in point-of-care settings. Sci. Rep. 6, 28274. https://doi.org/10.1038/srep28274 (2016).
doi: 10.1038/srep28274 pubmed: 27306485 pmcid: 4910285
Ohishi, W. & Chayama, K. Treatment of chronic hepatitis B with nucleos(t)ide analogues. Hepatol. Res. 42, 219–225 (2012).
doi: 10.1111/j.1872-034X.2011.00921.x pubmed: 22176139
Ye, X. et al. Efficient inhibition of Hepatitis B Virus infection by a preS1-binding peptide. Sci. Rep. 6, 29391. https://doi.org/10.1038/srep29391 (2016).
doi: 10.1038/srep29391 pubmed: 27384014 pmcid: 4935942
Seeger, C. & Mason, W. S. Hepatitis B Virus Biology. Microbiol. Mol. Biol. Rev. 64, 51–68 (2000).
doi: 10.1128/MMBR.64.1.51-68.2000 pubmed: 10704474 pmcid: 98986
Meier, A., Mehrle, S., Weiss, T. S., Mier, W. & Urban, S. Myristoylated PreS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytes. Hepatology. 58, 31–42 (2013).
doi: 10.1002/hep.26181 pubmed: 23213046
Hellstrom, U., Lindh, M., Krogsgaard, K. & Sylvan, S. Demonstration of an association between detection of IgG antibody reactivity towards the C-terminal region of the preS1 protein of hepatitis B virus and the capacity to respond to interferon therapy in chronic hepatitis B. J. Gastroenterol. Hepatol. 23, 804–810 (2008).
doi: 10.1111/j.1440-1746.2007.05174.x pubmed: 17931371
Wai, C. T., Chu, C. J., Hussain, M. & Lok, A. S. F. HBV genotype B is associated with better response to interferon therapy in HBeAg(+) chronic hepatitis than genotype C. Hepatology. 36, 1425–1430 (2002).
doi: 10.1002/hep.1840360619 pubmed: 12447868
Kirkwood, T. B. L. & Tydeman, M. S. Design and analysis of accelerated degradation tests for the stability of biological standards II. A flexible computer program for data analysis. J. Biol. Stand. 12, 207–214 (1984).
doi: 10.1016/S0092-1157(84)80055-4 pubmed: 6547442
Lago, B. V. et al. Genetic variability of hepatitis B virus in acute and in different phases of chronic infection in Brazil. Sci. Rep. 14, 10742. https://doi.org/10.1038/s41598-024-60900-2 (2024).
doi: 10.1038/s41598-024-60900-2 pubmed: 38730249 pmcid: 11087654
Razavi-Shearer, D. et al. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol. Hepatol. 3, 383–403 (2018).
doi: 10.1016/S2468-1253(18)30056-6
Chiu, S. M. et al. Associations of HBV genotype B vs C infection with Relapse after Cessation of Entecavir or Tenofovir Therapy. Clin. Gastroenterol. Hepatol. 18, 2989–2997 (2020).
doi: 10.1016/j.cgh.2020.04.048 pubmed: 32353534
Peng, X., Chen, L. & Xiao, M. Entecavir/peginterferon alfa-2a combination in the treatment of two genotypes of chronic hepatitis B patients with lamivudine resistance. Trop. J. Pharm. Res. 22, 901–907 (2023).
doi: 10.4314/tjpr.v22i4.25
Zhang, B. et al. Hepatitis B virus genotype is an independent prognostic factor of telbivudine and tenofovir treatment in hepatitis B surface antigen-positive pregnant women. Food Sci. Nutr. 10, 3–11 (2022).
doi: 10.1002/fsn3.2619 pubmed: 35035905
Jardi, R. et al. Analysis of hepatitis B genotype changes in chronic hepatitis B infection: influence of antiviral therapy. J. Hepatol. 49, 695–701 (2008).
doi: 10.1016/j.jhep.2008.03.030 pubmed: 18490074
Wen, J. et al. Hepatitis B virus genotype, mutations, human leukocyte antigen polymorphisms and their interactions in hepatocellular carcinoma: a multi-centre case-control study. Sci. Rep. 5, 16489. https://doi.org/10.1038/srep16489 (2015).
doi: 10.1038/srep16489 pubmed: 26568165 pmcid: 4644975
Varghese, N. et al. Review of related factors for persistent risk of Hepatitis B Virus-Associated Hepatocellular Carcinoma. Cancers. 16, 777. https://doi.org/10.3390/cancers16040777 (2024).
Wiegand, S. B. et al. Soluble immune markers in the different phases of chronic hepatitis B virus infection. Sci. Rep. 9, 14118. https://doi.org/10.1038/s41598-019-50729-5 (2019).
doi: 10.1038/s41598-019-50729-5 pubmed: 31575964 pmcid: 6773856
Utama, A. et al. Low prevalence of hepatitis B virus pre-s deletion mutation in Indonesia. J. Med. Virol. 83, 1717–1726 (2011).
doi: 10.1002/jmv.22172 pubmed: 21837787
Gao, Y. et al. Serum Hepatitis B Virus DNA, RNA, and HBsAg: which correlated better with Intrahepatic Covalently closed circular DNA before and after Nucleos(t)ide Analogue Treatment? J. Clin. Microbiol. 55, 2972–2982 (2017).
doi: 10.1128/JCM.00760-17 pubmed: 28747369 pmcid: 5625383
Robert, X. & Gouet, P. Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res. 42, W320–W324 (2014).
doi: 10.1093/nar/gku316 pubmed: 24753421 pmcid: 4086106

Auteurs

Yumin Li (Y)

Key Laboratory of Bionic Engineering (Ministry of Education), Jilin University, Changchun, 130022, China.

Li Wang (L)

Key Laboratory of Bionic Engineering (Ministry of Education), Jilin University, Changchun, 130022, China.

Huanyi Cheng (H)

Beijing Abace Biotechnology, Beijing, 100176, China.

Xiumei Chi (X)

Core Facility, The First Hospital of Jilin University, Jilin University, Changchun, 130021, China.

Qingrui Huang (Q)

Beijing Abace Biotechnology, Beijing, 100176, China.

Pinxin Lv (P)

Department of Neurosurgery, China-Japan Union Hospital of Jilin University, Jilin University, 130033, Changchun, China.

Wenyi Zhang (W)

Beijing Abace Biotechnology, Beijing, 100176, China.

Junqi Niu (J)

Department of Hepatology, The First Hospital of Jilin University, Jilin University, 130021, Changchun, China.

Xiaoyu Wen (X)

Department of Hepatology, The First Hospital of Jilin University, Jilin University, 130021, Changchun, China. xywen@jlu.edu.cn.

Zhenning Liu (Z)

Key Laboratory of Bionic Engineering (Ministry of Education), Jilin University, Changchun, 130022, China. liu_zhenning@jlu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH